Orna Therapeutics Expands Leadership Team with Key Executive Hires

CAMBRIDGE, Mass. December 16, 2021 – Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics (oRNATM), today announced the appointments of Robert Mabry, Ph.D. as Chief Scientific Officer, and Nishla Keiser, Ph.D., J.D. as Chief Legal and Strategy Officer.